speaker-icon

Latest Posts

anavex_partex_partnership_Innoplexus

27

Jun 23

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to...
Read More
Kittu-Press-Release

9

Feb 23

AI supports targeted therapy recommendations fortumor diseases – BMBF funds joint research projectat University Medical Center Mainz with 2.53 millionEuros

The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

AI pharma

ai-practical-solution-pharma

Why AI Is a Practical Solution for Pharma

Artificial intelligence, or AI, is gaining more attention in the pharma space these days. At one time evoking images from futuristic science fiction, it now plays a significant role in smartphones, cars, search engines, and financial transactions. But what, exactly, is artificial intelligence? It is a set of very specialized algorithms trained to solve very …

Why AI Is a Practical Solution for Pharma Read More »

ai-makes-identifying-biomarkers-more-accurate

How AI Makes Identifying Biomarkers More Accurate and Efficient

Current approaches to drug development that rely solely on identifying statistical differences between healthy and diseased patients to pinpoint biomarkers, molecular targets, or suitable drugs often fail to provide biologically useful results. While these differences can help predict which patients are likely to have misregulation of a particular gene, receptor, or protein, the majority of …

How AI Makes Identifying Biomarkers More Accurate and Efficient Read More »